Emmessar Biotech & Nutrition Ltd Financials

Emmessar Biotech & Nutrition Ltd Financial Statement

Emmessar Biotech & Nutrition Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Sep 2024	Jun 2024	Mar 2024
Revenue	0.85	0.54	0.56
Operating Expense	0.42	0.35	0.47
Net Profit	0.28	0.09	0.37
Net Profit Margin	32.94	16.67	66.07
Earning Per Share	0.56	0.18	0.71
EBIDTA	0.40	0.14	0.22
Effective Tax Rate	23.26	16.67	-188.89

Particulars	Sep 2024
Revenue	0.85
Operating Expense	0.42
Net Profit	0.28
Net Profit Margin	32.94
Earning Per Share	0.56
EBIDTA	0.40
Effective Tax Rate	23.26

Emmessar Biotech & Nutrition Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Total Revenue Annual	0.56	1.02	0.36
Operating Expenses Annual	1.64	1.71	1.26
Operating Profit Annual	0.91	1.06	1.02
Interest Annual	TBA	TBA	TBA
Depreciation	0.10	0.09	0.09
Net Profit Annual	0.75	0.50	0.48
Tax Annual	0.06	0.46	0.46

Particulars	Mar 2024
Total Revenue Annual	0.56
Operating Expenses Annual	1.64
Operating Profit Annual	0.91
Interest Annual	TBA
Depreciation	0.10
Net Profit Annual	0.75
Tax Annual	0.06

Emmessar Biotech & Nutrition Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Cash Flow at the Beginning	0.01	0.18	0.53
Cash Flow from Operations	0.64	0.38	2.27
Cash Flow from Investing	-0.64	-0.55	-2.61
Cash Flow from Financing	TBA	TBA	TBA
Cash Flow at the End	0.01	0.01	0.18

Particulars	Mar 2024
Cash Flow at the Beginning	0.01
Cash Flow from Operations	0.64
Cash Flow from Investing	-0.64
Cash Flow from Financing	TBA
Cash Flow at the End	0.01

Emmessar Biotech & Nutrition Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	162.50	103.92	283.33
PBIT Margin (%)	144.64	95.10	258.33
PBT Margin (%)	144.64	95.10	258.33
Net PROFIT Margin (%)	133.93	49.02	133.33
Return On Networth / Equity (%)	10.65	7.79	8.09
Return On Networth /Employed (%)	10.31	13.37	14.16
Return On Assets (%)	9.38	6.86	6.67
Total Debt / Equity (X)	0.01	0.01	TBA
Asset Turnover Ratio (%)	0.07	0.14	0.05

Particulars	Mar 2024
PBDIT Margin (%)	162.50
PBIT Margin (%)	144.64
PBT Margin (%)	144.64
Net PROFIT Margin (%)	133.93
Return On Networth / Equity (%)	10.65
Return On Networth /Employed (%)	10.31
Return On Assets (%)	9.38
Total Debt / Equity (X)	0.01
Asset Turnover Ratio (%)	0.07

Emmessar Biotech & Nutrition Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Fixed Assets Annual	1.31	1.40	1.46
Total Current Assets Annual	6.83	5.93	4.86
Non Current Assets Annual	1.91	2.01	2.35
Total Shareholders Funds Annual	7.40	6.66	6.17
Total Assets Annual	8.74	7.94	7.21

Particulars	Mar 2024
Fixed Assets Annual	1.31
Total Current Assets Annual	6.83
Non Current Assets Annual	1.91
Total Shareholders Funds Annual	7.40
Total Assets Annual	8.74

Emmessar Biotech & Nutrition Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

Get Your FAQs Right

As of Dec 26, 2024, Emmessar Biotech & Nutrition Ltd has a market capitalization of 14.86 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Emmessar Biotech & Nutrition Ltd is debt-free with a debt-to-equity ratio of 0.01.

In FY 2023 , Emmessar Biotech & Nutrition Ltd recorded a total revenue of approximately 0.56 Cr marking a significant milestone in the company's financial performance.

Emmessar Biotech & Nutrition Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.0% and 0.2% annually, respectively..

Emmessar Biotech & Nutrition Ltd's current PE ratio is 19.81.

Emmessar Biotech & Nutrition Ltd's ROCE averaged 12.3% from the FY ending March 2022 to 2024, with a median of 13.1%. It peaked at 13.7% in March 2022, reflecting strong capital efficiency over the period..

Emmessar Biotech & Nutrition Ltd's latest EBIT is Rs. 0.81 Cr, surpassing the average EBIT of Rs. 0.90 Cr over the 5 years..